Seer to Participate in Upcoming September Investor Conferences
08 Settembre 2023 - 10:05PM
Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced company
management will be participating in the following investor
conferences:
- Morgan Stanley 21st Annual Global
Healthcare Conference in New York, NY. Fireside chat on Wednesday,
September 13th at 12:15 p.m. Eastern Time
- Gilmartin Group Emerging Growth
Company Showcase, Virtual. Presentation on Thursday, September 21st
at 1:30 p.m. Eastern Time
A live webcast of the sessions will be available on the Investor
section of Seer’s website at investor.seer.bio. Archived replays
will be available on the company’s website following the
conference.
About SeerSeer™ is a life sciences company
developing transformative products that open a new gateway to the
proteome. Seer’s Proteograph™ Product Suite is an integrated
solution that includes proprietary engineered nanoparticles,
consumables, automation instrumentation and software to perform
deep, unbiased proteomic analysis at scale in a matter of hours.
Seer designed the Proteograph workflow to be efficient and easy to
use, leveraging widely adopted laboratory instrumentation to
provide a decentralized solution that can be incorporated by nearly
any lab. Seer’s Proteograph Product Suite is for research use only
and is not intended for diagnostic procedures. For more
information, please visit www.seer.bio.
Investor Contact:Carrie
Mendivilinvestor@seer.bio
Media Contact:Karen Possematopr@seer.bio
Grafico Azioni Seer (NASDAQ:SEER)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Seer (NASDAQ:SEER)
Storico
Da Giu 2023 a Giu 2024